51
|
Nonent M, Ben Salem D, Serfaty JM, Buthion V, Pasco-Papon A, Rotaru C, Bressollette L, Papon X, Pachai C, Fortrat JO, Gouny P, Badra A, Berge J, Le Bras Y, Cottier JP, Gauvrit JY, Douek P. Overestimation of moderate carotid stenosis assessed by both Doppler US and contrast enhanced 3D-MR angiography in the CARMEDAS study. J Neuroradiol 2010; 38:148-55. [PMID: 20728218 DOI: 10.1016/j.neurad.2010.05.002] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2010] [Revised: 05/01/2010] [Accepted: 05/20/2010] [Indexed: 11/18/2022]
Abstract
PURPOSE To evaluate the agreement and diagnostic accuracy of Contrast enhanced magnetic resonance angiography (CE-MRA), Doppler ultrasound (DUS) and Digital subtraction angiography (DSA) in the assessment of carotid stenosis. METHODS DUS, CE-MRA and DSA were performed in 56 patients included in the Carotide-angiographie par résonance magnétique-échographie-doppler-angioscanner (CARMEDAS) multicenter study with a carotid stenosis ≥ 50%. Three readers evaluated stenoses on CE-MRA and DSA (NASCET criteria). Velocities criteria were used for stenosis estimation on DUS. RESULTS CE-MRA had a sensitivity and specificity of 96-98% and 66-83% respectively for carotid stenoses ≥ 50% and a sensitivity and specificity of 94% and 76-84% respectively for carotid stenoses ≥ 70%. The interobserver agreement of CE-MRA was excellent, except for moderate stenoses (50-69%). DUS had a sensitivity and specificity of 88 and 75% respectively for carotid stenoses ≥ 50% and a sensitivity and specificity of 83 and 86% respectively for carotid stenoses ≥ 70%. Combined concordant CE-MRA and DUS had a sensitivity and specificity of 100 and 85-90% respectively for carotid stenoses ≥ 50% and a sensitivity and specificity of 96-100% and 80-87% respectively for carotid stenoses ≥ 70%. The positive predictive value of the association CE-MRA and DUS for carotid stenoses ≥ 70% is calculated between 77 and 82% while the negative predictive value is calculated between 97 and 100%. CE-MRA and DUS have concordant findings in 63-72%, and the overestimations cases were recorded only for carotid stenosis ≤ 69%. CONCLUSION Combined DUS-CE-MRA is excellent for evaluation of severe stenosis but remains debatable in moderate stenosis (50-69%) due to the risk of overestimations.
Collapse
Affiliation(s)
- M Nonent
- Department of Radiology, University Hospital Center, hôpital de la Cavale-Blanche, boulevard Tanguy-Prigent, 29609 Brest cedex, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
54
|
de Weerd M, Greving JP, Hedblad B, Lorenz MW, Mathiesen EB, O'Leary DH, Rosvall M, Sitzer M, Buskens E, Bots ML. Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis. Stroke 2010; 41:1294-7. [PMID: 20431077 DOI: 10.1161/strokeaha.110.581058] [Citation(s) in RCA: 242] [Impact Index Per Article: 17.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
BACKGROUND AND PURPOSE In the discussion on the cost-effectiveness of screening, precise estimates of severe asymptomatic carotid stenosis are vital. Accordingly, we assessed the prevalence of moderate and severe asymptomatic carotid stenosis by age and sex using pooled cohort data. METHODS We performed an individual participant data meta-analysis (23 706 participants) of 4 population-based studies (Malmö Diet and Cancer Study, Tromsø, Carotid Atherosclerosis Progression Study, and Cardiovascular Health Study). Outcomes of interest were asymptomatic moderate (> or =50%) and severe carotid stenosis (> or =70%). RESULTS Prevalence of moderate asymptomatic carotid stenosis ranged from 0.2% (95% CI, 0.0% to 0.4%) in men aged <50 years to 7.5% (5.2% to 10.5%) in men aged > or =80 years. For women, this prevalence increased from 0% (0% to 0.2%) to 5.0% (3.1% to 7.5%). Prevalence of severe asymptomatic carotid stenosis ranged from 0.1% (0.0% to 0.3%) in men aged <50 years to 3.1% (1.7% to 5.3%) in men aged > or =80. For women, this prevalence increased from 0% (0.0% to 0.2%) to 0.9% (0.3% to 2.4%). CONCLUSIONS The prevalence of severe asymptomatic carotid stenosis in the general population ranges from 0% to 3.1%, which is useful information in the discussion on the cost-effectiveness of screening.
Collapse
Affiliation(s)
- Marjolein de Weerd
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Internal mail Str 6.131, PO Box 85500, 3508 GA Utrecht, The Netherlands
| | | | | | | | | | | | | | | | | | | |
Collapse
|
58
|
Wardlaw JM, Stevenson MD, Chappell F, Rothwell PM, Gillard J, Young G, Thomas SM, Roditi G, Gough MJ. Carotid Artery Imaging for Secondary Stroke Prevention. Stroke 2009; 40:3511-7. [DOI: 10.1161/strokeaha.109.557017] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background and Purpose—
Patients with transient ischemic attack require carotid imaging to diagnose carotid stenosis. The differing sensitivity/specificity and availability of carotid imaging methods have created uncertainty over which noninvasive method is best and whether intra-arterial angiography is still required. We evaluated the influence of carotid imaging methods on secondary stroke prevention.
Methods—
We modeled the effect of different carotid imaging strategies and timing on endarterectomy workload, stroke, and death at 1 and 5 years. We used all available data on stroke prevention after transient ischemic attack from systematic reviews (carotid imaging, medical and surgical interventions), population-based transient ischemic attack/stroke studies, government statistics, and stroke prevention clinics.
Results—
Choice of imaging strategy affected speed of assessment, strokes prevented, and endarterectomy workload. The number of strokes prevented at 5 years varied by up to 22 per 1000 patients between imaging strategies for a given time to assessment. Delaying endarterectomy from 14 to approximately 30 days would fail to prevent up to 11 strokes per 1000 patients depending on the imaging strategy. Sensitive fast imaging (eg, ultrasound) was best for patients seen early; specific imaging (eg, CT angiography or contrast-enhanced MR angiography) was best for patients seen late after transient ischemic attack. Intra-arterial angiography conferred no advantage over noninvasive imaging.
Conclusions—
Rapid access to sensitive noninvasive carotid imaging prevents most strokes. However, imaging strategies differ in their effect on stroke prevention by as much as 22 per 1000 patients and optimal imaging varies with time after transient ischemic attack TIA. Routine intra-arterial angiography should be avoided.
Collapse
Affiliation(s)
- Joanna M. Wardlaw
- From the University of Edinburgh (J.M.W., F.C.), Edinburgh, UK; the University of Sheffield (M.S., S.T.), Sheffield, UK; the University of Cambridge (J.G.), Cambridge, UK; Leeds Teaching Hospital NHS Trust and University of Leeds (M.G.), St James Hospital and Leeds General Hospital, Leeds, UK; The James Cook University Hospital (G.Y.), Middlesbrough, UK; University of Oxford (P.M.R.), Oxford, UK; and Glasgow Royal Infirmary (G.R.), Glasgow, UK
| | - Matt D. Stevenson
- From the University of Edinburgh (J.M.W., F.C.), Edinburgh, UK; the University of Sheffield (M.S., S.T.), Sheffield, UK; the University of Cambridge (J.G.), Cambridge, UK; Leeds Teaching Hospital NHS Trust and University of Leeds (M.G.), St James Hospital and Leeds General Hospital, Leeds, UK; The James Cook University Hospital (G.Y.), Middlesbrough, UK; University of Oxford (P.M.R.), Oxford, UK; and Glasgow Royal Infirmary (G.R.), Glasgow, UK
| | - Francesca Chappell
- From the University of Edinburgh (J.M.W., F.C.), Edinburgh, UK; the University of Sheffield (M.S., S.T.), Sheffield, UK; the University of Cambridge (J.G.), Cambridge, UK; Leeds Teaching Hospital NHS Trust and University of Leeds (M.G.), St James Hospital and Leeds General Hospital, Leeds, UK; The James Cook University Hospital (G.Y.), Middlesbrough, UK; University of Oxford (P.M.R.), Oxford, UK; and Glasgow Royal Infirmary (G.R.), Glasgow, UK
| | - Peter M. Rothwell
- From the University of Edinburgh (J.M.W., F.C.), Edinburgh, UK; the University of Sheffield (M.S., S.T.), Sheffield, UK; the University of Cambridge (J.G.), Cambridge, UK; Leeds Teaching Hospital NHS Trust and University of Leeds (M.G.), St James Hospital and Leeds General Hospital, Leeds, UK; The James Cook University Hospital (G.Y.), Middlesbrough, UK; University of Oxford (P.M.R.), Oxford, UK; and Glasgow Royal Infirmary (G.R.), Glasgow, UK
| | - Jonathan Gillard
- From the University of Edinburgh (J.M.W., F.C.), Edinburgh, UK; the University of Sheffield (M.S., S.T.), Sheffield, UK; the University of Cambridge (J.G.), Cambridge, UK; Leeds Teaching Hospital NHS Trust and University of Leeds (M.G.), St James Hospital and Leeds General Hospital, Leeds, UK; The James Cook University Hospital (G.Y.), Middlesbrough, UK; University of Oxford (P.M.R.), Oxford, UK; and Glasgow Royal Infirmary (G.R.), Glasgow, UK
| | - Gavin Young
- From the University of Edinburgh (J.M.W., F.C.), Edinburgh, UK; the University of Sheffield (M.S., S.T.), Sheffield, UK; the University of Cambridge (J.G.), Cambridge, UK; Leeds Teaching Hospital NHS Trust and University of Leeds (M.G.), St James Hospital and Leeds General Hospital, Leeds, UK; The James Cook University Hospital (G.Y.), Middlesbrough, UK; University of Oxford (P.M.R.), Oxford, UK; and Glasgow Royal Infirmary (G.R.), Glasgow, UK
| | - Steven M. Thomas
- From the University of Edinburgh (J.M.W., F.C.), Edinburgh, UK; the University of Sheffield (M.S., S.T.), Sheffield, UK; the University of Cambridge (J.G.), Cambridge, UK; Leeds Teaching Hospital NHS Trust and University of Leeds (M.G.), St James Hospital and Leeds General Hospital, Leeds, UK; The James Cook University Hospital (G.Y.), Middlesbrough, UK; University of Oxford (P.M.R.), Oxford, UK; and Glasgow Royal Infirmary (G.R.), Glasgow, UK
| | - Giles Roditi
- From the University of Edinburgh (J.M.W., F.C.), Edinburgh, UK; the University of Sheffield (M.S., S.T.), Sheffield, UK; the University of Cambridge (J.G.), Cambridge, UK; Leeds Teaching Hospital NHS Trust and University of Leeds (M.G.), St James Hospital and Leeds General Hospital, Leeds, UK; The James Cook University Hospital (G.Y.), Middlesbrough, UK; University of Oxford (P.M.R.), Oxford, UK; and Glasgow Royal Infirmary (G.R.), Glasgow, UK
| | - Michael J. Gough
- From the University of Edinburgh (J.M.W., F.C.), Edinburgh, UK; the University of Sheffield (M.S., S.T.), Sheffield, UK; the University of Cambridge (J.G.), Cambridge, UK; Leeds Teaching Hospital NHS Trust and University of Leeds (M.G.), St James Hospital and Leeds General Hospital, Leeds, UK; The James Cook University Hospital (G.Y.), Middlesbrough, UK; University of Oxford (P.M.R.), Oxford, UK; and Glasgow Royal Infirmary (G.R.), Glasgow, UK
| |
Collapse
|